4//SEC Filing
Hamel Lawrence G 4
Accession 0001209191-18-055127
CIK 0001427925other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 4:30 PM ET
Size
5.4 KB
Accession
0001209191-18-055127
Insider Transaction Report
Form 4
Hamel Lawrence G
Chief Development Officer
Transactions
- Sale
Common Stock
2018-10-15$5.00/sh−5,216$26,080→ 29,795 total(indirect: By Trust)
Holdings
- 24,371
Common Stock
Footnotes (1)
- [F1]Shares sold pursuant to a 10b5-1 plan.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeother
Related Parties
1- filerCIK 0001511368
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 4:30 PM ET
- Size
- 5.4 KB